✦ LIBER ✦

Treatment of chronic myopathies in horses with the serotonin S2-antagonist R 50970: A preclinical study

✍ Scribed by Leo A. A. Ooms; Anne-Dominique A. Y. Degryse; Jan L. A. Fransen; Kris A. C. van Mol

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 367 KB
Volume: 8
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.430080126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized study on the treatment of chr

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha

✍ Hehlmann, R. ;Anger, B. ;Messerer, D. ;Zankovich, R. ;Bergmann, L. ;Kolb, H. J. 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 453 KB

Treatment of chronic ulcers in the lower

Treatment of chronic ulcers in the lower extremities with topical becaplermin gel .01%: A multicenter open-label study

✍ E. Guzman-Gardearzabal; G. Leyva-Bohorquez; S. Salas-Colín; J. L. Paz-Janeiro; R 📂 Article 📅 2000 🏛 Springer Healthcare Communications 🌐 English ⚖ 170 KB

A phase III study of the safety and effi

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

✍ Yves Benhamou; Nezam H. Afdhal; David R. Nelson; Mitchell L. Shiffman; Deanine G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

Pegylated interferon (peg-IFN) and ribavirin (RBV) are effective in eradicating the hepatitis C virus in more than half of patients. However, anemia arising from RBV-induced hemolysis can prompt dose reductions and lower sustained virologic response (SVR) rates. In early clinical trials, Viramidine